Free Trial

Synaptogenix (SNPX) News Today

Synaptogenix logo
$2.46 -0.22 (-8.02%)
As of 10:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Synaptogenix Inc Ordinary Shares
Synaptogenix Announces $5.0 Million Financing
Short Volatility Alert: Synaptogenix Inc
SNPX - Synaptogenix, Inc.
SNPX.O
Synaptogenix Welcomes Lecanemab Phase 3 Trial Results
Synaptogenix Announces Live Ap - GuruFocus.com
Remove Ads
Get Synaptogenix News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNPX and its competitors with MarketBeat's FREE daily newsletter.

SNPX Media Mentions By Week

SNPX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNPX
News Sentiment

-0.56

0.82

Average
Medical
News Sentiment

SNPX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNPX Articles
This Week

2

0

SNPX Articles
Average Week

Remove Ads
Get Synaptogenix News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNPX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SNPX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners